Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-13T02:01:05.177Z Has data issue: false hasContentIssue false
  • English
  • Français

New research advances in ethno-psychopharmacology: an Asian perspective

Published online by Cambridge University Press:  02 January 2018

Edmond H. Pi  and
Weiguo Zhu
Edmond H. Pi
Affiliation:
Department of Psychiatry and Behavioral Sciences, University of Southern California, Keck School of Medicine, 2020 Zonal Avenue, IRD, Los Angeles, CA 90033, USA, email ehpi@usc.edu
Weiguo Zhu
Affiliation:
Department of Psychiatry and Behavioral Sciences, University of Southern California, Keck School of Medicine, 2020 Zonal Avenue, IRD, Los Angeles, CA 90033, USA, email ehpi@usc.edu
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Asians represent more than half the world's population but themselves consist of very diverse genetic, ethnic, cultural and linguistic groups. Understanding the role of ethnicity in an individual's response to psychotropic medications is of importance in treating psychiatric disorders among Asians. Recent research has supported the notion that Asians carry distinct genetic profiles that can influence both the pharmacokinetics and the pharmacodynamics of a given medication (Lin & Smith, 2000; Pi & Simpson, 2005). In this brief review, we summarise the research findings in the field, focusing on pharmacogenetic variations between Asians and other ethnic groups.

Type
Thematic Papers - Ethno-psychopharmacology
Information
International Psychiatry , Volume 4 , Issue 3 , July 2007 , pp. 57 - 58
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Royal College of Psychiatrists 2007

References

Agarwal, D. P. & Goedde, H. P. (1990) Alcohol Metabolism, Alcohol Intolerance and Alcoholism: Biochemical and Pharmacogenetic Approaches. Springer.CrossRefGoogle Scholar
Gelernter, J., Kranzler, H. & Cubells, J. F. (1997) Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Human Genetics, 101, 234–246.CrossRefGoogle ScholarPubMed
Glatt, S. J., Faraone, S. V. & Tsuang, M. T. (2003) Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry, 160, 469–476.Google Scholar
Lin, K. M. & Smith, M. W. (2000) Psychopharmacology in the context of culture and ethnicity. In Ethnicity and Pharmacology (Review of Psychiatry Series, Vol. 19) (ed. Ruiz, P.), pp. 1–36. American Psychiatric Press.Google Scholar
Lin, K. M., Lau, J. K., Smith, M. W., et al (1988a) Comparison of alprazolam plasma levels and behavioral effects in normal Asian and Caucasian male volunteers. Psychopharmacology (Berlin), 96, 365–369.Google Scholar
Lin, K. M., Poland, R. E., Lau, J. K., et al (1988b) Haloperidol and prolactin concentrations in Asians and Caucasians. Journal of Clinical Psychopharmacology, 8, 195–201.CrossRefGoogle ScholarPubMed
Ng, C. H., Easteal, S., Tan, S., et al (2006) Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 953–957.Google Scholar
Pi, E. H. & Gray, G. E. (2000) Ethnopharmacology for Asians. In Ethnicity and Pharmacology (Review of Psychiatry Series, Vol. 19) (ed. Ruiz, P.), pp. 91–113. American Psychiatric Press.Google Scholar
Pi, E. H. & Simpson, G. M. (2000) Medication-induced movement disorders. In Kaplan and Sadock's Comprehensive Textbook of Psychiatry (7th edn) (eds Sadock, B. J. & Sadock, V. A.), pp. 2265–2271. Lippincott, Williams & Wilkins.Google Scholar
Pi, E. H. & Simpson, G. M. (2005) Cross-culture psychopharmacology: a current clinical perspective. Journal of Psychiatric Services, 56, 31–33.Google Scholar
Potkin, S. G., Shen, Y., Pardes, H., et al (1984) Haloperidol concentrations elevated in Chinese patients. Psychiatry Research, 12, 167–172.Google Scholar
Wall, T. L., Shea, S. H., Chan, K. K., et al (2001) A genetic association with the development of alcohol and other substance use behavior in Asian Americans. Journal of Abnormal Psychology, 110, 173–178.Google Scholar
Yang, Y. Y., Yeh, E. K., Chang, S. S., et al (1991) Maintenance lithium levels could be lowered: based on Taiwanese and Danish studies. Journal of the Formosan Medical Association, 90, 509–513.Google Scholar
Zhou, H. H., Adedoyin, A. & Wilkinson, G. R. (1990) Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clinical Pharmacology and Therapeutics, 48, 10–17.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.